ReviewJornal brasileiro de nefrologia

Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we "gliflozin" patients with kidney stone disease?

Mauricio de Carvalho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.